Literature DB >> 6354777

Impaired counterregulation of hypoglycemia in insulin-dependent diabetes mellitus.

J Kleinbaum, H Shamoon.   

Abstract

We evaluated the recovery of blood glucose after insulin-induced hypoglycemia in six insulin-dependent diabetics (insulin-infused and initially euglycemic) and six normal controls after comparable reductions in plasma glucose. In contrast to controls, the recovery of plasma glucose was delayed in diabetics (2-h plasma glucose 80 +/- 5 mg/dl and 58 +/- 5 mg/dl, respectively, P less than 0.01). This delay was due to the absence of a rebound in hepatic glucose output in the diabetics, whereas glucose output rose two- to threefold above baseline in normals. The impaired rebound in glucose output in diabetics could not be attributed to hyperinsulinemia. Rather, hypoglycemia-induced secretion of epinephrine and glucagon was reduced in the diabetics by 60-80% as compared with normals (P less than 0.001). The diabetics did not suffer from overt neuropathy and plasma cortisol, growth hormone, and norepinephrine increased normally following hypoglycemia. The data suggest that prolonged hypoglycemia may frequently occur in tightly controlled type I diabetics because of impaired rebound in hepatic glucose release which in turn may be a consequence of reduced secretion of epinephrine and glucagon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354777     DOI: 10.2337/diab.32.6.493

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation.

Authors:  Luisa M Rodríguez; Richard J Knight; Rubina A Heptulla
Journal:  Diabetes Technol Ther       Date:  2010-05       Impact factor: 6.118

2.  Role of hepatic autoregulation in defense against hypoglycemia in humans.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; M Ventura; P Campbell; P Brunetti; J E Gerich
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

3.  Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.

Authors:  R E Ryder; D R Owens; T M Hayes; M A Ghatei; S R Bloom
Journal:  BMJ       Date:  1990-10-06

4.  Management of diabetes mellitus.

Authors:  M B Davidson
Journal:  West J Med       Date:  1984-03

5.  Beta-adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes.

Authors:  H Shamoon; R Sherwin
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

6.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.

Authors:  H Shamoon; S Friedman; C Canton; L Zacharowicz; M Hu; L Rossetti
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 8.  Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment.

Authors:  H Shamoon
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Quantitative measurement of islet glucagon response to hypoglycemia by confocal fluorescence imaging in diabetic rats: effects of phlorizin treatment.

Authors:  K S Rastogi; R L Cooper; Z Q Shi; M Vranic
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

10.  Thioredoxin-1 Overexpression in the Ventromedial Nucleus of the Hypothalamus Preserves the Counterregulatory Response to Hypoglycemia During Type 1 Diabetes in Male Rats.

Authors:  Chunxue Zhou; Vanessa H Routh
Journal:  Diabetes       Date:  2017-10-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.